<DOC>
	<DOCNO>NCT00434590</DOCNO>
	<brief_summary>The study evaluate kidney graft function maintenance renal transplant patient .</brief_summary>
	<brief_title>Efficacy Tolerability Full Dose Enteric-coated Mycophenolate Sodium , Addition Cyclosporine Microemulsion Reduced Dose , Maintenance Renal Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Inclusion criterion : Male female recipient single double renal transplant perform since least one year 5 year Age &gt; 18 yrs Adequate stable renal function Informed consent . Exclusion criterion : Kidney transplant combine organ ; Significant proteinuria Severe ongoing infection ; Present historical malignant neoplasia , type , exception excise non metastatic nonmelanoma skin cancer previous malignant neoplasia cure since least 5 year ; Relapse endstage renal disease transplant kidney ; Leucopenia , thrombocytopenia severe anemia ; Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Kidney Transplantation</keyword>
	<keyword>Mycophenolic Acid</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Cyclosporine</keyword>
</DOC>